This search is based on observations that the effects of oral glucose can't always be fully explained by GLP-1 and GIP alone, suggesting another player might be on the field
1 Lilly posted $65.18 billion in FY2025 revenue, up 44.7% year-over-year, the largest growth rate among the top 20 pharma companies
Compounded medications are custom-prepared by a licensed compounding pharmacy using active pharmaceutical ingredients sourced from FDA-registered facilities, but the finished compounded product itself doesn't go through the FDA's new drug approval process for safety, effectiveness, and manufacturing quality the way brand-name medications like Ozempic or Wegovy do
Global NASH Council, American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Canadian Association for the Study of the Liver, European Liver Patients' Association - ELPA, Global Liver Institute, Priti Chawla, Obesity Matters, American Diabetes Association Fatty Liver Alliances Post GLP-1 receptor agonists (GLP-1RAs) show promise in managing metabolic dysfunction-associated steatotic liver disease (MASLD) by reducing hepatic steatosis, resolving MASH, and mitigating fibrosis progression
